Skip to main content Accessibility help
×
Hostname: page-component-76fb5796d-22dnz Total loading time: 0 Render date: 2024-04-25T13:26:39.955Z Has data issue: false hasContentIssue false

2 - Tumour growth, stem cells and experimental chemotherapy

Published online by Cambridge University Press:  03 May 2010

James H. Goldie
Affiliation:
University of British Columbia, Vancouver
Andrew J. Coldman
Affiliation:
University of British Columbia, Vancouver
Get access

Summary

Introduction

Much of what has been learned concerning the properties of cancer cells has been developed from studies of a variety of cell lines that have been adapted for growth in tissue culture or in appropriate experimental animals. A variety of mammalian (chiefly rodent) and human cancer cell lines have been developed for this purpose. It has to be kept in mind that the properties of these highly selected experimental systems may differ from those that one might expect to find occurring in primary tumours in patients. Despite this caveat, it is apparent that many principles that have been learned from the experimental systems have been valuable in the understanding of human malignancy.

Any line of tumour cells that has adapted to growing in tissue culture or through serial transplantation in animals will have been subject to an extremely rigorous selection process. Normal (i.e. nonmalignant) fibroblasts in tissue culture will die out after they have undergone a number of sequential cell divisions (approximately 50). This appears to be the case no matter how carefully the culture conditions are established. This also appears to be true for many cancer cells in that there appears to be an upper limit to the number of sequential divisions they will undergo before becoming senescent and dying. Some tumour cells, however, become ‘immortalized’ and they will replicate indefinitely in the right type of environment. Recently, it has been suggested that an important step in the process whereby cells become immortal is related to the expression of the enzyme telomerase.

Type
Chapter
Information
Drug Resistance in Cancer
Mechanisms and Models
, pp. 24 - 58
Publisher: Cambridge University Press
Print publication year: 1998

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×